Evoke Pharma Inc. (EVOK)
NASDAQ: EVOK
· Real-Time Price · USD
5.08
-0.06 (-1.17%)
At close: Aug 15, 2025, 3:59 PM
5.00
-1.48%
After-hours: Aug 15, 2025, 07:53 PM EDT
Evoke Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.08M | 3.31M | 2.65M | 2.55M | 1.74M | 1.68M | 1.56M | 1.13M | 810.41K | 796.37K | 832.1K | 461.8K | 418.38K | 360.57K | 930.45K | 236.63K | 90.42K |
Cost of Revenue | 41.61K | 118.5K | 104.02K | 41.48K | 92.53K | 59.02K | 34.91K | 57.36K | 50.59K | 190.08K | 89.78K | 67.77K | 22.76K | 136.68K | 58.44K | 68.25K | 64.75K |
Gross Profit | 3.04M | 3.19M | 2.55M | 2.51M | 1.64M | 1.62M | 1.53M | 1.07M | 759.82K | 606.29K | 742.33K | 394.02K | 395.62K | 223.89K | 872.01K | 168.38K | 25.67K |
Operating Income | -1.3M | -1.19M | -1.29M | -1.22M | -1.5M | -1.89M | -1.6M | -1.78M | -2.16M | -1.71M | -1.91M | -2.11M | -2.05M | -1.55M | -1.84M | -2.17M | -2.59M |
Interest Income | 118.85K | 126.96K | 99.29K | 81K | 46.06K | 26.54K | 35.56K | 41.16K | 35.33K | 32.59K | 24.71K | 3.91K | 795.00 | 1.02K | 1.42K | 3.01K | 3.16K |
Pretax Income | -1.31M | -1.19M | -1.31M | -1.27M | -1.58M | -1.99M | -1.69M | -1.87M | -2.24M | -1.8M | -2.01M | -2.23M | -2.17M | -1.67M | -1.97M | -2.29M | -2.61M |
Net Income | -1.31M | -1.19M | -1.31M | -1.27M | -1.58M | -1.99M | -1.69M | -1.87M | -2.45M | -1.77M | -2.01M | -2.23M | -2.17M | -1.67M | -1.97M | -2.29M | -2.61M |
Selling & General & Admin | 4.3M | 4.38M | 3.82M | 3.73M | 3.14M | 3.48M | 3.13M | 2.77M | 2.85M | 2.29M | 2.61M | 2.32M | 2.41M | 1.74M | 2.64M | 2.14M | 2.34M |
Research & Development | 42.78K | n/a | 11.68K | n/a | 4.64K | 22.56K | n/a | 92.36K | 66.99K | 27.21K | 40.39K | 191.48K | 41.72K | 35.72K | 81.7K | 195.23K | 277.82K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 22.76K | n/a | n/a | n/a | n/a |
Operating Expenses | 4.34M | 4.38M | 3.84M | 3.73M | 3.14M | 3.5M | 3.13M | 2.86M | 2.91M | 2.32M | 2.65M | 2.51M | 2.45M | 1.77M | 2.72M | 2.34M | 2.62M |
Interest Expense | 123.29K | 126.03K | 126.03K | 124.66K | 124.66K | 126.03K | 126.03K | 124.66K | 123.29K | 126.03K | 126.03K | 124.66K | 123.29K | 126.03K | 126.03K | 124.66K | 123.34K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.38M | 4.5M | 3.94M | 3.77M | 3.24M | 3.56M | 3.17M | 2.92M | 2.97M | 2.51M | 2.74M | 2.57M | 2.47M | 1.91M | 2.78M | 2.41M | 2.68M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 211.25K | -32.59K | n/a | -3.91K | -795 | -1.02K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 2.55M | 1.49M | 1.4M | 1.36M | 756.81K | 278.59K | 278.59K | 278.59K | 278.59K | 278.59K | 278.59K | 263.08K | 227.62K | 226.78K | 225.99K | 224.9K | 216.38K |
Shares Outstanding (Diluted) | 2.55M | 1.49M | 1.4M | 1.36M | 756.81K | 278.59K | 278.59K | 278.59K | 278.59K | 278.59K | 278.59K | 263.08K | 227.62K | 226.78K | 225.99K | 224.9K | 216.38K |
EPS (Basic) | -0.51 | -0.8 | -0.94 | -0.93 | -2.09 | -7.13 | -6.08 | -6.7 | -8.81 | -6.36 | -7.23 | -8.47 | -9.55 | -7.37 | -8.71 | -10.19 | -12.04 |
EPS (Diluted) | -0.51 | -0.8 | -0.94 | -0.93 | -2.09 | -7.13 | -6.08 | -6.7 | -8.81 | -6.36 | -7.23 | -8.47 | -9.55 | -7.37 | -8.71 | -10.19 | -12.04 |
EBITDA | -1.18M | -1.07M | -1.19M | -1.14M | -1.46M | -1.86M | -1.57M | -1.74M | -2.12M | -1.68M | -1.89M | -2.11M | -2.05M | -1.55M | -1.84M | -2.17M | -2.48M |
EBIT | -1.18M | -1.07M | -1.19M | -1.14M | -1.46M | -1.86M | -1.57M | -1.74M | -2.12M | -1.68M | -1.89M | -2.11M | -2.05M | -1.55M | -1.84M | -2.17M | -2.48M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | 1.89M | 1.6M | 1.78M | 2.16M | 1.71M | 1.91M | 2.11M | 2.05M | 1.55M | 1.84M | 2.17M | 2.59M |